Clinical Trials and Cohort Studies Grants aim to support high-quality clinical trials and cohort studies that address important gaps in knowledge, leading to relevant and implementable findings for the benefit of human health. 

Clinical Trials and Cohort Studies Grants 

Clinical Trials and Cohort Studies Grants aim to support high-quality clinical trials and cohort studies that address important gaps in knowledge, leading to relevant and implementable findings for the benefit of human health. 

They will provide funding for up to five years. The amount of funding provided will be based on the assessment of the requested budget. Funds may be spent on Direct Research Costs (DRCs) and Personnel Support Packages (PSPs). Each Clinical Trials and Cohort Studies Grant may have up to 10 investigators.  A person may apply for, and hold more than one Clinical Trial and Cohort Studies Grant at any one time.  

Assessment criteria and weighting

Assessment of applications will focus on the significance, research quality, and team quality and capability of the proposal. 

Significance means the extent to which the research findings will substantially advance knowledge to improve the prevention, diagnosis or treatment of medical conditions, or to improve health and wellbeing and will count towards 40% of the final score. 

Research quality encompasses the quality and feasibility of the proposed research, incorporating theoretical concepts, hypothesis, research design and robustness and will count towards 40% of the final score. 

Team quality and capability will assess whether the Chief Investigator team named in your application has the appropriate mix of research skills and experience to undertake the clinical trial and/or cohort study and achieve the stated objectives of the proposed research and will count towards 20% of the final score.